Chih-Hsun Chu

1.0k total citations
22 papers, 308 citations indexed

About

Chih-Hsun Chu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Chih-Hsun Chu has authored 22 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Chih-Hsun Chu's work include Metabolism, Diabetes, and Cancer (4 papers), Thyroid Disorders and Treatments (4 papers) and Regulation of Appetite and Obesity (3 papers). Chih-Hsun Chu is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Thyroid Disorders and Treatments (4 papers) and Regulation of Appetite and Obesity (3 papers). Chih-Hsun Chu collaborates with scholars based in Taiwan. Chih-Hsun Chu's co-authors include Jenn‐Kuen Lee, Hing‐Chung Lam, Bang‐Ping Jiann, Chien‐Wen Chou, Sheng‐Hwu Hsieh, Kuang‐Chung Shih, Hsin‐Hung Chen, Ching‐Jiunn Tseng, Pei‐Wen Cheng and Ming‐Hong Tai and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Nutrients and Metabolism.

In The Last Decade

Chih-Hsun Chu

22 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih-Hsun Chu Taiwan 12 183 75 56 45 43 22 308
Güzin Fidan Yaylalı Türkiye 9 155 0.8× 95 1.3× 29 0.5× 65 1.4× 28 0.7× 37 360
Teruhisa Ueda Japan 12 200 1.1× 40 0.5× 101 1.8× 59 1.3× 53 1.2× 32 473
Ramis Çolak Türkiye 12 156 0.9× 13 0.2× 82 1.5× 61 1.4× 56 1.3× 35 451
Faruk Kılınç Türkiye 9 97 0.5× 31 0.4× 53 0.9× 45 1.0× 40 0.9× 34 330
Sartaj Sandhu United States 9 322 1.8× 18 0.2× 49 0.9× 44 1.0× 90 2.1× 18 470
E. Waldkirch Germany 12 144 0.8× 219 2.9× 46 0.8× 48 1.1× 76 1.8× 22 502
Szu‐Ju Chen Taiwan 10 32 0.2× 22 0.3× 56 1.0× 75 1.7× 19 0.4× 25 282
Yajing Wang China 10 102 0.6× 74 1.0× 36 0.6× 63 1.4× 54 1.3× 16 298
V. Christov Bulgaria 7 359 2.0× 68 0.9× 47 0.8× 55 1.2× 21 0.5× 14 411
Enrica Chebat Italy 10 98 0.5× 20 0.3× 46 0.8× 89 2.0× 46 1.1× 22 358

Countries citing papers authored by Chih-Hsun Chu

Since Specialization
Citations

This map shows the geographic impact of Chih-Hsun Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-Hsun Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-Hsun Chu more than expected).

Fields of papers citing papers by Chih-Hsun Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih-Hsun Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-Hsun Chu. The network helps show where Chih-Hsun Chu may publish in the future.

Co-authorship network of co-authors of Chih-Hsun Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chih-Hsun Chu. A scholar is included among the top collaborators of Chih-Hsun Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih-Hsun Chu. Chih-Hsun Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Chih-Hsun, et al.. (2025). The value of growth differentiation factor 15 as a biomarker for peripheral artery disease in diabetes patients. Diabetology & Metabolic Syndrome. 17(1). 31–31. 3 indexed citations
2.
Wang, Chih‐Yuan, Kuo‐Chin Huang, Chia‐Wen Lu, et al.. (2022). A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 107(10). e4063–e4071. 12 indexed citations
3.
Chu, Chih-Hsun, Chih‐Cheng Hsu, Shih‐Yi Lin, et al.. (2019). Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan. Journal of the Formosan Medical Association. 118. S74–S82. 12 indexed citations
4.
Tsai, Kuo‐Wang, et al.. (2015). A Novel Hemoglobin Variant Found on the α1 Chain: Hb KSVGH (HBA1: p.Lys57_Gly58insSerHisGlySerAlaGlnValLys). Hemoglobin. 39(2). 81–87. 3 indexed citations
5.
Chu, Chih-Hsun, et al.. (2012). Carotid intima-media thickness in Chinese Type 2 diabetic subjects with or without microalbuminuria.. PubMed. 35(3). 254–9. 2 indexed citations
6.
Chu, Chih-Hsun, et al.. (2011). Hyperthyroidism-Associated Insulin Resistance Is Not Mediated by Adiponectin Levels. Journal of Thyroid Research. 2011. 1–5. 15 indexed citations
8.
Hsieh, Sheng‐Hwu, Kuang‐Chung Shih, Chien‐Wen Chou, & Chih-Hsun Chu. (2010). Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas. Acta Diabetologica. 48(1). 71–77. 18 indexed citations
9.
Chu, Chih-Hsun, et al.. (2009). Common Hemoglobin Variants in Southern Taiwan and Their Effect on the Determination of HbA1c by Ion-exchange High-performance Liquid Chromatography. Journal of the Chinese Medical Association. 72(7). 362–367. 8 indexed citations
10.
Jiann, Bang‐Ping, et al.. (2009). Patterns and Their Correlates of Seeking Treatment for Erectile Dysfunction in Type 2 Diabetic Patients. The Journal of Sexual Medicine. 6(7). 2008–2016. 11 indexed citations
11.
Chu, Chih-Hsun, et al.. (2009). Color Doppler Sonography of the Neck in a Patient with Bilateral Carotid Body Tumors. Journal of Medical Ultrasound. 17(2). 114–119. 2 indexed citations
12.
Chu, Chih-Hsun, et al.. (2008). Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism. Metabolism. 57(10). 1380–1383. 24 indexed citations
13.
Chu, Chih-Hsun, et al.. (2007). Very Low HbA1c Values in a Patient with Clinical Silent Hemoglobin Variant (Hemoglobin J)-A Case Report. 18(1). 45–50. 4 indexed citations
14.
Lee, Jenn‐Kuen, et al.. (2007). Two-year effect of rosiglitazone in chinese poorly controlled type 2 diabetic patients.. PubMed. 29(5). 486–92. 1 indexed citations
15.
Lam, Hing‐Chung, et al.. (2006). The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia.. PubMed. 231(6). 1010–5. 16 indexed citations
16.
Chu, Chih-Hsun, et al.. (2006). Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.. PubMed. 231(6). 1040–3. 23 indexed citations
17.
Lam, Hing‐Chung, et al.. (2004). Immunoreactive Endothelin in Taiwanese Thyroid Cystic Fluid. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S418–S420. 1 indexed citations
18.
Lam, Hing‐Chung, et al.. (2004). Salivary Immunoreactive Endothelin in Patients with Upper Gastrointestinal Diseases. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S413–S417. 13 indexed citations
19.
Lam, Hing‐Chung, et al.. (2003). Role of Endothelin in Diabetic Retinopathy. Current Vascular Pharmacology. 1(3). 243–250. 24 indexed citations
20.
Chu, Chih-Hsun, et al.. (2003). Sclerotherapy of thyroid cystic nodules.. PubMed. 102(9). 625–30. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026